Articles in section Licensing
| << Joint Venture | 505 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 ..3 4 5 6 7 8 .. 51 | Next >> |
-
Pfizer Pledges up to US$4.4 B for Myovant’s Orgovyx
-
Merck KGaA Expands Head and Neck Cancer Therapy Portfolio with Debiopharm’s Xevinapant
-
Boston Pharmaceuticals In-Licenses Another Two Programmes from GSK
-
Novartis Licenses Mesoblast’s Stem Cell Therapy Remestemcel-L
-
Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche
-
Sanofi Delves Further into Protein Degrader Therapies with US$2.33 B Kymera Deal
-
Roche and Blueprint Medicines Partner Again in US$1.7 B Pralsetinib Pact
-
AstraZeneca Signs US$6 B ADC Collaboration with Daiichi Sankyo for DS-1062
-
CSL Behring Licenses Phase III Haemophilia B Gene Therapy Candidate from uniQure
-
Neurocrine Biosciences Licenses Seven Psychiatric Programmes from Takeda in US$2 B Deal
RSS